Publications of H. Urlaub
All genres
Conference Paper (26)
441.
Conference Paper
92 (Suppl), P1.1-006, (2019)
Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex. 71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, PA, May 04, 2019 - May 10, 2019. Neurology 442.
Conference Paper
78 (13), 2692, (2018)
Elucidation of the pre-B-cell receptor signaling network in acute lymphocytic leukemia cells. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Chicago, IL, April 14, 2018 - April 18, 2018. Cancer Research 443.
Conference Paper
39 (Suppl.), p. 219 - 219 (2016)
Elucidation of tonic and activated B cell receptor signaling in Burkitt's lymphoma reveals insights into non-oncogene addiction. Oncology Research and Treatment 444.
Conference Paper
101 (Suppl. 1), p. 166 - 166 (2016)
A novel epigenetic resistance mechanism to the FLT3 inhibitor PK412 induces cross-resistance to standard chemotherapy in acute myeloid leukemia (AML). 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, June 09, 2016 - June 12, 2016. Haematologica 445.
Conference Paper
101 (Suppl. 1), p. 45 - 45 (2016)
Identification of novel B cell receptor antigens in chronic lymphocytic leukemia. 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, June 09, 2016 - June 12, 2016. Haematologica 446.
Conference Paper
27, P1666, (2016)
Engineering nanobodies for super-resolution imaging and native protein complex isolation. Annual Meeting of the American Society for Cell Biology (ASCB), San Francisco, CA, December 03, 2016 - December 07, 2016. Molecular Biology of the Cell 447.
Conference Paper
126 (23), 2453, (2015)
Phosphoproteomic profiling of the signaling output of FLT3-ITD and its AC220-resistant mutants reveals profound signaling differences and differential responsiveness to inhibition of downstream kinases. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, December 05, 2015 - December 08, 2015. Blood 448.
Conference Paper
126 (23), (2015)
Identification of B cell receptor antigens in the chronic lymphocytic leukemia microenvironment. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, December 05, 2015 - December 08, 2015. Blood 449.
Conference Paper
10 (Suppl. 2), 9 Ed., pp. S293 - 293 (2015)
Proteomic profiling of pulmonary cancer with squamous cell histology. Journal of Thoracic Oncology 450.
Conference Paper
75 (Suppl. 15), 50, (2015)
Elucidation of B cell receptor signaling in Burkitt's lymphoma reveals novel signaling nodes with potential therapeutic relevance. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, April 18, 2015 - April 22, 2015. Cancer Research 451.
Conference Paper
282 (Suppl. 1), pp. 209 - 210 (2015)
Sequestering and protein cofactor competition regulate a multifunctional RNA helicase in different pathways. 40th Congress of the Federation of European Biochemical Societies (FEBS) - The Biochemical Basis of Life, Berlin, July 04, 2015 - July 09, 2015. FEBS Journal 452.
Conference Paper
15 (Suppl. 1), pp. S226 - S227 (2015)
Elucidation of B cell receptor signaling in Burkitt's lymphoma reveals novel signaling nodes with potential therapeutic relevance. Twentieth International Hematologic Malignancies 2014 Conference. Clinical Lymphoma Myeloma and Leukemia 453.
Conference Paper
100 (Suppl. 1), p. 178 - 178 (2015)
The B cell reseptor signaling output in Burkitt´s lymphoma is genotype specific and impacts sensitivity towards BCR signaling inhibitors. 20th Congress of the European Hematology Association , Vienna, Austria, June 11, 2015 - June 14, 2015. Haematologica 454.
Conference Paper
25, p. E57 - E57 (2014)
Exploring the complete spectrum of CRM1 cargoes. ASCB/IFCB Meeting, Philadelphia, PA, December 06, 2014 - December 10, 2014. Molecular Biology of the Cell 455.
Conference Paper
74 (Supplement S), 2487, 19 Ed., (2014)
Comprehensive quantitative proteomic profiling of lung cancers reveals novel biomarkers and potential drug targets. 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), San Diego, CA, April 05, 2014 - April 09, 2014. Cancer Research 456.
Conference Paper
37 (Suppl. 5), pp. 225 - 226 (2014)
Syk and Btk induce cell survival and proliferation in AML cells by activating distinct signaling pathways and transcriptional programs. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg, October 14, 2014 - October 16, 2014. Oncology Research and Treatment 457.
Conference Paper
74 (Supplement S), 4203, 19 Ed., (2014)
A transducer module consisting of Toll-like receptor 9 and Bruton's tyrosine kinase triggers acute myeloid leukemia blast proliferation. 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), San Diego, CA, April 05, 2014 - April 09, 2014. Cancer Research 458.
Conference Paper
124 (21), (2014)
Syk and Btk transduce survival and proliferation-inducing signals by activating distinct signaling pathways and transcriptional programs in AML cells. 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, December 06, 2014 - December 09, 2014. Blood 459.
Conference Paper
73 (Supplement 1), 1107, (2013)
β2 integrin–derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis. 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, April 06, 2013 - April 10, 2013. Cancer Research 460.
Conference Paper
26 (Supplement 2), p. S21 - S21 (2011)
Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders